Base
line
1 2 3 4 5 6 Mean P value
AH glargine 1.70
±
1.50
0.85
 ±
 0.89
0.50
±
0.59
0.38
±
0.66
0.65
±
1.05
0.38
±
0.70
0.13
±
0.33
0.65
±
0.51
       0.005
NPH 1.50
 ±
1.01
2.45
±
4.9
1.60
±
1.29
1.55
±
1.30
1.45
±
1.21
1.23
±
1.33
1.05
±
1.21
1.54
±
0.44
SymH glargine 1.20
 ±
 1.2
0.45
±
0.63
0.31
±
0.52
0.28
±
0.59
0.35
±
0.58
0.23
±
0 .53
0.05
±
0.31
0.41
±
0.36
    0.008
NPH 1.05
±
0.93
0.98
±
1.05
1.05
 ±
1.1
0.85
 ±
1.00
0.75
±
0.92
0.80
±
0 .91
0.70
±
0.99
0.88
±
0.14
SH glargine 0.65
±
0 .77
0.05
±
0.22
0.18
±
0.38
0.20
±
0.40
0.18
±
0.38
0.13
±
0.40
0.05
±
0.22
0.20
±
0.20
    0.0001
NPH 0.70
±
0.85
0.80
±
0.82
0.83
±
0.87
0.68
±
0.85
0.58
±
0.84
0.50
±
0.71
0.48
±
0.75
0.65
±
0.13
NH glargine 0.55
±
0.93
0.18
±
0.54
0.10
±
0.30
0.10
±
0.37
0.03
±
0.15
0.01
±
0.01
0.03
±
0.16
0.14
±
0.18
    0.748
NPH 0.53
±
0.91
0.21
±
0.56
0.18
±
0.44
0.09
±
0.32
0.04
±
0.19
0.08
±
0.34
0.09
±
0.28
0.17
±
0.16
Table 4: Mean episodes of hypoglycemia in the study groups at follow-up visits.